With more than 14 years’ experience in the antibody development industry, ProteoGenix provides efficient and accurate antibody humanization service based on an enhanced CDR grafting technique. We are committed to collaborate with our customers to help them meet their specific needs; our expertise ensures the success of your project.
Alternatively, our phage display platform can be used to screen antibodies from human libraries to avoid the need to humanize the antibodies.
Fundamental step in the advancement of drug discovery and development
Potential to improve biophysical properties of monoclonal antibodies while keeping their affinity and specificity
Improve affinity and production yields of the antibody